Effect of difelikefalin, a selective kappa opioid receptor agonist, on respiratory depression<b>:</b>A randomized, double‐blind, placebo‐controlled trial

Eugene R. Viscusi(Thomas Jefferson University), Sukirti Bagal(Cara Therapeutics (United States)), Marc C. Torjman(Thomas Jefferson University), Catherine Munera(Cara Therapeutics (United States)), Beatrice Setnik, Joseph Stauffer
Clinical and Translational Science
May 13, 2021
Cited by 34


Related Papers